EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Crinophagy in Pancreatic Beta Cells: From Insulin Granule Turnover to Diabetes Pathogenesis

Muralidharan Mani iD, Thomas F J Martin iD

Pathophysiology · 03.07.2026 · 33 (3) · 45

DOI: 10.3390/pathophysiology33030045 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathophysiology, online erschienen am 03.07.2026. Verfasst von Muralidharan Mani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic β-cells maintain glucose homeostasis through tightly regulated insulin biosynthesis, storage, and secretion. To prevent pathological accumulation of excess or aging secretory granules (SGs), β-cells use crinophagy, a selective lysosomal degradation pathway in which mature insulin-containing granules fuse directly with lysosomes to form hybrid organelles termed crinosomes. Crinophagy was historically considered a simple mechanism for discarding obsolete, aged SGs. The acidic, protease-rich environment of crinosomes is proposed to generate unconventional insulin-derived epitopes through cathepsin-mediated proteolysis and transpeptidation reactions. These cryptic epitopes, which include hybrid insulin peptides (HIPs) resulting from the covalent fusion of insulin fragments with peptides from co-resident granule proteins, are largely absent from the thymic epitope repertoire. This creates a “peripheral–thymic mismatch” that allows autoreactive CD4+ T cells to escape central tolerance, ultimately driving β-cell destruction in type 1 diabetes (T1D). Recent studies demonstrate that pharmacological or genetic inhibition of crinophagy reduces crinosome abundance, narrows the pathogenic epitope repertoire, and delays the onset of diabetes in preclinical models. In type 2 diabetes (T2D), a related pathway termed stress-induced nascent granule degradation (SINGD) diverts newly synthesized insulin granules to lysosomes under glucolipotoxic conditions, contributing to insulin depletion and progressive β-cell failure. This review summarizes the current understanding of the molecular mechanisms behind crinophagy. It discusses its two main functions: maintaining physiological quality control and generating pathological antigens. Additionally, the review explores how crinophagy interacts with other cellular stress pathways and highlights new therapeutic strategies aimed at targeting this process to protect pancreatic β-cell function and potentially prevent or delay diabetes.

Schlagwörter

Stichwörter der Autor:innen

SINGDcathepsin Dcrinophagycrinosomeshybrid insulin peptidesinsulin secretory granulespancreatic beta cellsperipheral–thymic mismatchtype 1 diabetestype 2 diabetes

Autor:innen und Institutionen

  • Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706, USA.

ORCID-Profile: Muralidharan Mani, Thomas F J Martin

Förderung

  • NIDDK NIH HHS
  • NIH

Zitieren

APA

Mani, M., & Martin, T. F. J. (2026). Crinophagy in Pancreatic Beta Cells: From Insulin Granule Turnover to Diabetes Pathogenesis. Pathophysiology, 33(3), 45. https://doi.org/10.3390/pathophysiology33030045

Vancouver

Mani M, Martin TFJ. Crinophagy in Pancreatic Beta Cells: From Insulin Granule Turnover to Diabetes Pathogenesis. Pathophysiology. 2026;33(3):45. doi:10.3390/pathophysiology33030045

BibTeX
@article{Mani2026,
  author = {Mani, Muralidharan and Martin, Thomas F J},
  title = {Crinophagy in Pancreatic Beta Cells: From Insulin Granule Turnover to Diabetes Pathogenesis},
  journal = {Pathophysiology},
  year = {2026},
  volume = {33},
  number = {3},
  pages = {45},
  doi = {10.3390/pathophysiology33030045}
}
Kostenlos starten →